{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:45:13Z","timestamp":1766180713029},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"School of Pharmacy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The study aims to evaluate factors influencing pharmacists' management of eye infections following the reclassification of ophthalmic chloramphenicol to pharmacist supply.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data were collected using a self-administered questionnaire posted to a random sample of community pharmacies in urban and rural areas in Western Australia. Data were entered into Excel and analysed using SPSS v17 (SPSS Inc., Chicago, IL, USA) and SAS v9.2 (SAS Institute Inc., Cary, NC, USA). Descriptive statistics were used to summarise the responses and demographics of respondents. Regression analysis was used to identify relationships between variables. Factor analysis was conducted to pool variables and the derived factors were subjected to regression analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Of the 240 community pharmacies surveyed, 119 (49.5%) responded (79% urban and 21% rural pharmacies). Urban and rural pharmacies provided ophthalmic chloramphenicol over-the-counter (OTC) 3\u20134 and 1\u20132 times weekly, respectively (P = 0.021), with some pharmacies providing 12 or more per week. Over 82% of respondents claimed that sales of other OTC products used for acute bacterial conjunctivitis had \u2018decreased\/decreased markedly\u2019. A majority of respondents (59%) claimed that there was no change in the number of prescriptions received for ophthalmic chloramphenicol. Most respondents (76.4%) agreed\/strongly agreed that pharmacist's current level of training was adequate to provide ophthalmic chloramphenicol. However, approximately one-fifth (21.8%) responded that pharmacists required some additional training.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Down-scheduling of ophthalmic chloramphenicol has improved pharmacists' capability to treat acute bacterial conjunctivitis, largely as a replacement for products previously available OTC, rather than fewer general practitioner consultations. Pharmacists showed overall support for the reclassification as it enabled better use of professional skills and patient access to improved treatment options.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/ijpp.12119","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T09:13:10Z","timestamp":1400577190000},"page":"111-120","source":"Crossref","is-referenced-by-count":6,"title":["An evaluation of the reclassification of ophthalmic chloramphenicol for the management of acute bacterial conjunctivitis in community pharmacies in Western Australia"],"prefix":"10.1093","volume":"23","author":[{"given":"Luma","family":"Alkhatib","sequence":"first","affiliation":[{"name":"Curtin Health and Innovation Research Institute, School of Pharmacy, Curtin University, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Parsons","sequence":"additional","affiliation":[{"name":"Curtin Health and Innovation Research Institute, School of Pharmacy, Curtin University, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Czarniak","sequence":"additional","affiliation":[{"name":"Curtin Health and Innovation Research Institute, School of Pharmacy, Curtin University, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian B","family":"Sunderland","sequence":"additional","affiliation":[{"name":"Curtin Health and Innovation Research Institute, School of Pharmacy, Curtin University, Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"2021020207061497800_ijpp12119-bib-0001","first-page":"553","article-title":"Increasing the number of drugs available over the counter: arguments for and against","volume":"45","author":"Bradley","year":"1995","journal-title":"Br J Gen Pract"},{"key":"2021020207061497800_ijpp12119-bib-0002","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2165\/00002018-200326150-00001","article-title":"Issues related to monitoring the safety of over-the-counter (OTC) medicines","volume":"26","author":"Bond","year":"2003","journal-title":"Drug Saf"},{"key":"2021020207061497800_ijpp12119-bib-0003","volume-title":"Therapeutic Goods Aministration Poisons Standard","year":"2012"},{"key":"2021020207061497800_ijpp12119-bib-0004","volume-title":"National Drugs and Poisons Schedule Committee: Record of Reasons of Meeting 57","author":"Therapeutic Goods Administration","year":"2009"},{"key":"2021020207061497800_ijpp12119-bib-0005","first-page":"697","article-title":"Chloramphenicol eye drops approved as pharmacy medicine for treatment of bacterial conjunctivitis.","volume":"274","author":"","year":"2005","journal-title":"Pharm J"},{"key":"2021020207061497800_ijpp12119-bib-0006","volume-title":"Chloramphenicol OTC switch gets thumbs up","author":"","year":"2005"},{"key":"2021020207061497800_ijpp12119-bib-0007","volume-title":"AMA out of Touch on Chloramphenicol","author":"O'Donoghue","year":"2010"},{"key":"2021020207061497800_ijpp12119-bib-0008","volume-title":"Bettering the Evaluation and Care of Health (BEACH)","author":"","year":"2010"},{"key":"2021020207061497800_ijpp12119-bib-0009","first-page":"44","article-title":"Topical chloramphenicol for eye infections","volume":"8","author":"Lam","year":"2002","journal-title":"Hong Kong Med J"},{"key":"2021020207061497800_ijpp12119-bib-0010","first-page":"962","article-title":"Topical antibiotics for acute bacterial conjunctivitis","volume":"55","author":"Sheikh","year":"2005","journal-title":"Brit J Gen Pract"},{"key":"2021020207061497800_ijpp12119-bib-0011","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/bjo.80.2.182","article-title":"Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia?","volume":"80","author":"McGhee","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"2021020207061497800_ijpp12119-bib-0012","doi-asserted-by":"crossref","DOI":"10.1201\/b13787","volume-title":"Kucers' The Use of Antibiotics","author":"Grayson","year":"2010","edition":"6th"},{"key":"2021020207061497800_ijpp12119-bib-0013","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0420.2007.01006.x","article-title":"Acute bacterial conjunctivitis","volume":"86","author":"H\u00f8vding","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"2021020207061497800_ijpp12119-bib-0014","first-page":"725","article-title":"Conjuctivitis and chloramphenicol","volume":"247","author":"Elton","year":"2005","journal-title":"Pharm J"},{"key":"2021020207061497800_ijpp12119-bib-0015","first-page":"1","article-title":"Antibiotics versus placebo for acute bacterial conjunctivitis","volume":"9","author":"Sheikh","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2021020207061497800_ijpp12119-bib-0016","volume-title":"Infective Conjunctivitis","author":"","year":"2013"},{"key":"2021020207061497800_ijpp12119-bib-0017","volume-title":"Conjunctivitis","author":"","year":"2013"},{"key":"2021020207061497800_ijpp12119-bib-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1197\/j.aem.2006.08.006","article-title":"Clinical features of bacterial conjunctivitis in children","volume":"14","author":"Patel","year":"2007","journal-title":"Acad Emerg Med"},{"key":"2021020207061497800_ijpp12119-bib-0019","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/bmj.c1016","article-title":"Over the counter chloramphenicol eye drops","volume":"340","author":"Scott","year":"2010","journal-title":"Br Med J"},{"key":"2021020207061497800_ijpp12119-bib-0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/ijpp.18.05.00046.x","article-title":"Prescribing and sale of oththalmic chloramphenicol following reclassification to over-the-counter availability","volume":"18","author":"Walker","year":"2010","journal-title":"Int J Pharm Pract"},{"key":"2021020207061497800_ijpp12119-bib-0021","volume-title":"Antibiotic Use: OTC antibiotic surge sparks resistance fears","author":"","year":"2008"},{"key":"2021020207061497800_ijpp12119-bib-0022","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/bmj.312.7031.617","article-title":"General practitioners' views on over the counter sales by community pharmacists","volume":"312","author":"Erwin","year":"1996","journal-title":"Br Med J"},{"key":"2021020207061497800_ijpp12119-bib-0023","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/fampra\/cmh723","article-title":"Societal perspectives on over-the-counter (OTC) medicines","volume":"22","author":"Wazaify","year":"2005","journal-title":"Fam Pract"},{"key":"2021020207061497800_ijpp12119-bib-0024","volume-title":"Provision of Chloramphenicol for Opthalmic Use as a Pharmacist Only Medicine","author":"The Pharmaceuteutical Society of Australia","year":"2010"},{"key":"2021020207061497800_ijpp12119-bib-0025","volume-title":"Using Multivariate Statistics","author":"Tabachnick","year":"2007","edition":"5th"},{"key":"2021020207061497800_ijpp12119-bib-0026","volume-title":"Pharmacy Access Remoteness Index of Australia","author":""}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijpp.12119","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/23\/2\/111\/36164152\/ijpp12119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/23\/2\/111\/36164152\/ijpp12119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T07:55:29Z","timestamp":1612338929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/23\/2\/111\/6101799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,5,20]]},"published-print":{"date-parts":[[2015,3,10]]}},"URL":"https:\/\/doi.org\/10.1111\/ijpp.12119","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,4]]},"published":{"date-parts":[[2014,5,20]]}}}